Appendix 3A.1 - Notification of dividend / distribution Appendix 3A.1 - Notification of dividend / distribution 1 / 5 Announcement Summary Entity name NEUREN PHARMACEUTICALS LIMITED Security on which the Distribution will be paid NEU - ORDINARY FULLY PAID Announcement Type New announcement...
Dividend/Distribution - NEU
Filed with ASX ·
6ix hasn’t read this filing yet.
Neuren Pharmaceuticals Limited on 6ix
In the deck
Story so far
Earlier from Neuren Pharmaceuticals
- Investor presentation, 26 August 2026
- Growing royalty anchors Neuren first ever dividend program
- Half Yearly Report and Accounts
- European Commission grants marketing authorisation for DAYBU
- Neuren H1 2026 Financial Results Webinar on 26 August 2026
Later from Neuren Pharmaceuticals
- Corporate Presentation, 2 September 2026
- Update - Dividend/Distribution - NEU
- Pause in Trading
- Trofinetide US patent protections extended to March 2041
- FDA grants Orphan Drug Designation for NNZ-2591 to treat HIE
Follow Neuren Pharmaceuticals into a list and get an email when it puts out news.
Follow Neuren Pharmaceuticals